Shah H, Patel P, Nath A, Shah U, Sarkar R
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40072555
DOI: 10.1007/s00210-025-03957-8.
Leung M, Swanton C, McGranahan N
Nat Rev Genet. 2025; .
PMID: 40065153
DOI: 10.1038/s41576-025-00825-2.
Mehdikhani F, Hajimehdipoor H, Tansaz M, Maresca M, Rajabi S
Biomolecules. 2025; 15(2).
PMID: 40001571
PMC: 11852507.
DOI: 10.3390/biom15020268.
Esparza S, Jacobs E, Hammel J, Michelhaugh S, Alinezhadbalalami N, Nagai-Singer M
Ann Biomed Eng. 2025; .
PMID: 39998766
DOI: 10.1007/s10439-024-03674-y.
Zhang L, Duan X, Zhao Y, Zhang D, Zhang Y
Front Immunol. 2025; 16:1526589.
PMID: 39995663
PMC: 11847830.
DOI: 10.3389/fimmu.2025.1526589.
Invasion and metastasis in cancer: molecular insights and therapeutic targets.
Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X
Signal Transduct Target Ther. 2025; 10(1):57.
PMID: 39979279
PMC: 11842613.
DOI: 10.1038/s41392-025-02148-4.
Exploring the anti-metastatic potential of sunitinib and novel analogs in colorectal cancer: insights into HIF-1α mediated metastasis.
Rassouli F, Matin M, Hadizadeh F, Nejabat M, Allahverdizadeh H, Jamali H
Front Pharmacol. 2025; 16:1520881.
PMID: 39968177
PMC: 11832664.
DOI: 10.3389/fphar.2025.1520881.
Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.
Lopez-Collazo E, Hurtado-Navarro L
Front Immunol. 2025; 16:1524781.
PMID: 39967663
PMC: 11832717.
DOI: 10.3389/fimmu.2025.1524781.
Molecular principles underlying aggressive cancers.
Nussinov R, Yavuz B, Jang H
Signal Transduct Target Ther. 2025; 10(1):42.
PMID: 39956859
PMC: 11830828.
DOI: 10.1038/s41392-025-02129-7.
Efficacy Analysis of Hypofractionated Radiotherapy for Oligometastatic Tumors: A Retrospective Study.
Sun Q, Zhao H, Zhang X, Zhang S, He Z, Wang G
Technol Cancer Res Treat. 2025; 24():15330338241310155.
PMID: 39819190
PMC: 11742154.
DOI: 10.1177/15330338241310155.
Intercellular signaling stabilizes single-cell level phenotypic transitions and accelerates the reestablishment of equilibrium of heterogeneous cancer cell populations.
Lopez D, Tyson D, Hong T
bioRxiv. 2025; .
PMID: 39803530
PMC: 11722408.
DOI: 10.1101/2025.01.03.631250.
Advances in microfluidic platforms for tumor cell phenotyping: from bench to bedside.
Joshi R, Ahmadi H, Gardner K, Bright R, Wang W, Li W
Lab Chip. 2025; 25(5):856-883.
PMID: 39774602
PMC: 11859771.
DOI: 10.1039/d4lc00403e.
The crucial role of CEMIP in cancer metastasis: Mechanistic insights and clinical implications.
Ko Y, Jo J, Song S, Lee H
FASEB J. 2025; 39(1):e70284.
PMID: 39758005
PMC: 11701794.
DOI: 10.1096/fj.202402522R.
Pan-cancer drivers of metastasis.
Lusby R, Demirdizen E, Inayatullah M, Kundu P, Maiques O, Zhang Z
Mol Cancer. 2025; 24(1):2.
PMID: 39748426
PMC: 11697158.
DOI: 10.1186/s12943-024-02182-w.
Accelerated growth and local progression of radiorecurrent prostate cancer in an orthotopic bioluminescent mouse model.
Frame G, Huang X, Haas R, Khan K, Leong H, Kislinger T
Sci Rep. 2024; 14(1):31205.
PMID: 39732766
PMC: 11682066.
DOI: 10.1038/s41598-024-82546-w.
The metastatic cascade through the lens of therapeutic inhibition.
Miranda I, Jahan N, Shevde L
Cell Rep Med. 2024; 6(1):101872.
PMID: 39706193
PMC: 11866422.
DOI: 10.1016/j.xcrm.2024.101872.
Mycobacteria Treatment Inhibits Bladder Cancer Cell Migration, Invasion, and Anchorage-Independent Growth.
Bach-Griera M, Hernandez A, Julian E
Int J Mol Sci. 2024; 25(23).
PMID: 39684712
PMC: 11641630.
DOI: 10.3390/ijms252312997.
Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues.
Sanghvi N, Calvo-Alcaniz C, Rajagopal P, Scalera S, Canu V, Sinha S
Sci Adv. 2024; 10(49):eadn0220.
PMID: 39642223
PMC: 11623296.
DOI: 10.1126/sciadv.adn0220.
A systematic review of candidate genes and their relevant pathways for metastasis among adults diagnosed with breast cancer.
Gehling G, Alfaqih M, Pruinelli L, Starkweather A, Dungan J
Breast Cancer Res. 2024; 26(1):165.
PMID: 39593069
PMC: 11590482.
DOI: 10.1186/s13058-024-01914-6.
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives.
Lombardo C, Fazio R, Sinagra M, Gattuso G, Longo F, Lombardo C
J Pers Med. 2024; 14(11).
PMID: 39590575
PMC: 11595780.
DOI: 10.3390/jpm14111083.